PTAB Denies Hedge Fund's Bid For Biogen Patent Review
The Patent Trial and Appeal Board has dealt another setback to an organization with close ties to hedge fund manager Kyle Bass, declining Wednesday to institute an America Invents Act review...To view the full article, register now.
Already a subscriber? Click here to view full article